Our previous studies showed that the antiapoptotic activity of NR4A1 was due in part to the regulation of pro-survival genes with GC-rich promoters such as survivin (mechanism 1) [6] and maintenance of intracellular oxidative stress at low levels in cancer cells (mechanism 2) [9]. The gene discussed is BIRC5; the disease is cancer.